25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cytogen Inc
Buy, Hold or Sell?

Let's analyze Cytogen Inc together

I guess you are interested in Cytogen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cytogen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cytogen Inc

I send you an email if I find something interesting about Cytogen Inc.

1. Quick Overview

1.1. Quick analysis of Cytogen Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cytogen Inc? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,367.36
Expected worth in 1 year
₩4,403.46
How sure are you?
30.8%

+ What do you gain per year?

Total Gains per Share
₩2,036.10
Return On Investment
40.0%

For what price can you sell your share?

Current Price per Share
₩5,090.00
Expected price per share
₩0 - ₩6,540
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cytogen Inc (5 min.)




Live pricePrice per Share (EOD)
₩5,090.00

2.2. Growth of Cytogen Inc (5 min.)




Is Cytogen Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$38.1m$4.8m$25.8m84.3%

How much money is Cytogen Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$2.8m$72.7k2.6%
Net Profit Margin-461.7%-1,881.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cytogen Inc (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cytogen Inc?

Welcome investor! Cytogen Inc's management wants to use your money to grow the business. In return you get a share of Cytogen Inc.

First you should know what it really means to hold a share of Cytogen Inc. And how you can make/lose money.

Speculation

The Price per Share of Cytogen Inc is ₩5,090. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cytogen Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cytogen Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,367.36. Based on the TTM, the Book Value Change Per Share is ₩509.03 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-53.91 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cytogen Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.090.0%-0.120.0%-0.090.0%-0.080.0%-0.070.0%
Usd Book Value Change Per Share-0.080.0%0.360.0%-0.040.0%0.050.0%0.060.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.080.0%0.360.0%-0.040.0%0.050.0%0.060.0%
Usd Price Per Share5.78-9.02-12.44-20.62-16.80-
Price to Earnings Ratio-16.11--21.83--36.93--218.40--176.55-
Price-to-Total Gains Ratio-75.60-39.84--119.50--243.65--238.84-
Price to Book Ratio3.49-12.71-71.92-45.70-36.62-
Price-to-Total Gains Ratio-75.60-39.84--119.50--243.65--238.84-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.563
Number of shares280
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.360.05
Usd Total Gains Per Share0.360.05
Gains per Quarter (280 shares)99.7714.57
Gains per Year (280 shares)399.0858.30
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1039938905848
207987880117106
30119711870175164
40159615860233222
50199519850291280
60239423840350338
70279427830408396
80319331820466454
90359235810525512
100399139800583570

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.026.00.00.0%0.026.00.00.0%
Book Value Change Per Share3.01.00.075.0%4.08.00.033.3%6.014.00.030.0%8.017.01.030.8%8.017.01.030.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.026.00.0%0.00.026.00.0%
Total Gains per Share3.01.00.075.0%4.08.00.033.3%6.014.00.030.0%8.017.01.030.8%8.017.01.030.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cytogen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---109.261509.026-121%-53.906-51%74.357-247%91.052-220%
Book Value Per Share--2367.3571900.492+25%299.036+692%931.548+154%834.995+184%
Current Ratio--17.27910.248+69%0.612+2722%12.138+42%12.595+37%
Debt To Asset Ratio--0.2780.356-22%0.827-66%0.472-41%0.396-30%
Debt To Equity Ratio--0.3860.657-41%6.167-94%1.909-80%1.516-75%
Dividend Per Share----0%-0%-0%-0%
Eps---128.190-172.161+34%-134.076+5%-118.536-8%-99.046-23%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap117321955000.000-62%190388870000.000296935183750.000-36%409704862500.000-54%678853360572.388-72%553311688049.596-66%
Net Profit Margin---2.475-4.617+87%-18.810+660%-37.115+1399%-31.104+1157%
Operating Margin----0%-16.3660%-11.8650%-11.7730%
Operating Ratio--1.9154.787-60%5.154-63%9.013-79%10.071-81%
Pb Ratio2.150-62%3.48912.714-73%71.919-95%45.695-92%36.624-90%
Pe Ratio-9.927+38%-16.109-21.829+36%-36.933+129%-218.398+1256%-176.546+996%
Price Per Share5090.000-62%8260.00012882.500-36%17775.000-54%29451.978-72%24005.366-66%
Price To Free Cash Flow Ratio----30.8240%-26.4860%-11.4620%-8.8170%
Price To Total Gains Ratio-46.586+38%-75.59939.843-290%-119.505+58%-243.646+222%-238.843+216%
Quick Ratio---1.088-100%0.610-100%11.195-100%9.152-100%
Return On Assets---0.039-0.071+81%-0.101+159%-0.071+82%-0.068+75%
Return On Equity---0.054-0.128+136%-0.791+1361%-0.260+380%-0.272+403%
Total Gains Per Share---109.261509.026-121%-53.906-51%74.357-247%91.052-220%
Usd Book Value--38196473.00030663768.182+25%4824838.559+692%15030202.880+154%13472349.108+184%
Usd Book Value Change Per Share---0.0760.356-121%-0.038-51%0.052-247%0.064-220%
Usd Book Value Per Share--1.6571.330+25%0.209+692%0.652+154%0.584+184%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.090-0.121+34%-0.094+5%-0.083-8%-0.069-23%
Usd Free Cash Flow----1195889.2700%-1527253.6020%-544628.5740%-418945.0570%
Usd Market Cap82125368.500-62%133272209.000207854628.625-36%286793403.750-54%475197352.401-72%387318181.635-66%
Usd Price Per Share3.563-62%5.7829.018-36%12.443-54%20.616-72%16.804-66%
Usd Profit---2068300.500-2777750.047+34%-2850477.445+38%-2049972.502-1%-1703798.791-18%
Usd Revenue--835609.600621903.734+34%382122.780+119%255119.383+228%223654.380+274%
Usd Total Gains Per Share---0.0760.356-121%-0.038-51%0.052-247%0.064-220%
 EOD+3 -4MRQTTM+16 -10YOY+17 -95Y+14 -1210Y+14 -12

3.3 Fundamental Score

Let's check the fundamental score of Cytogen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.927
Price to Book Ratio (EOD)Between0-12.150
Net Profit Margin (MRQ)Greater than0-2.475
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than117.279
Debt to Asset Ratio (MRQ)Less than10.278
Debt to Equity Ratio (MRQ)Less than10.386
Return on Equity (MRQ)Greater than0.15-0.054
Return on Assets (MRQ)Greater than0.05-0.039
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Cytogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.318
Ma 20Greater thanMa 506,960.500
Ma 50Greater thanMa 1007,200.200
Ma 100Greater thanMa 2007,659.700
OpenGreater thanClose6,290.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Cytogen Inc

Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 12:16:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cytogen Inc earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -247.5% means that ₩-2.48 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cytogen Inc:

  • The MRQ is -247.5%. The company is making a huge loss. -2
  • The TTM is -461.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-247.5%TTM-461.7%+214.2%
TTM-461.7%YOY-1,881.0%+1,419.3%
TTM-461.7%5Y-3,711.5%+3,249.7%
5Y-3,711.5%10Y-3,110.4%-601.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-247.5%-5.4%-242.1%
TTM-461.7%-9.1%-452.6%
YOY-1,881.0%-0.8%-1,880.2%
5Y-3,711.5%-3.0%-3,708.5%
10Y-3,110.4%-0.7%-3,109.7%
4.3.1.2. Return on Assets

Shows how efficient Cytogen Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • -3.9% Return on Assets means that Cytogen Inc generated ₩-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cytogen Inc:

  • The MRQ is -3.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-7.1%+3.2%
TTM-7.1%YOY-10.1%+3.1%
TTM-7.1%5Y-7.1%+0.1%
5Y-7.1%10Y-6.8%-0.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-1.2%-2.7%
TTM-7.1%-2.1%-5.0%
YOY-10.1%-0.9%-9.2%
5Y-7.1%-0.3%-6.8%
10Y-6.8%-0.5%-6.3%
4.3.1.3. Return on Equity

Shows how efficient Cytogen Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • -5.4% Return on Equity means Cytogen Inc generated ₩-0.05 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cytogen Inc:

  • The MRQ is -5.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-12.8%+7.4%
TTM-12.8%YOY-79.1%+66.3%
TTM-12.8%5Y-26.0%+13.2%
5Y-26.0%10Y-27.2%+1.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.4%-0.4%-5.0%
TTM-12.8%-1.7%-11.1%
YOY-79.1%0.3%-79.4%
5Y-26.0%-0.9%-25.1%
10Y-27.2%-0.9%-26.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cytogen Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cytogen Inc is operating .

  • Measures how much profit Cytogen Inc makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cytogen Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-1,636.6%+1,636.6%
TTM-5Y-1,186.5%+1,186.5%
5Y-1,186.5%10Y-1,177.3%-9.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.6%+9.6%
TTM--14.9%+14.9%
YOY-1,636.6%3.3%-1,639.9%
5Y-1,186.5%0.5%-1,187.0%
10Y-1,177.3%3.1%-1,180.4%
4.3.2.2. Operating Ratio

Measures how efficient Cytogen Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.91 means that the operating costs are ₩1.91 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Cytogen Inc:

  • The MRQ is 1.915. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.787. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.915TTM4.787-2.873
TTM4.787YOY5.154-0.367
TTM4.7875Y9.013-4.226
5Y9.01310Y10.071-1.058
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9151.254+0.661
TTM4.7871.294+3.493
YOY5.1541.266+3.888
5Y9.0131.208+7.805
10Y10.0711.191+8.880
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cytogen Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cytogen Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 17.28 means the company has ₩17.28 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Cytogen Inc:

  • The MRQ is 17.279. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.248. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ17.279TTM10.248+7.031
TTM10.248YOY0.612+9.636
TTM10.2485Y12.138-1.890
5Y12.13810Y12.595-0.457
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ17.2792.028+15.251
TTM10.2482.076+8.172
YOY0.6122.585-1.973
5Y12.1382.646+9.492
10Y12.5953.229+9.366
4.4.3.2. Quick Ratio

Measures if Cytogen Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cytogen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.088-1.088
TTM1.088YOY0.610+0.477
TTM1.0885Y11.195-10.108
5Y11.19510Y9.152+2.043
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.228-1.228
TTM1.0881.233-0.145
YOY0.6101.803-1.193
5Y11.1952.069+9.126
10Y9.1522.435+6.717
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cytogen Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cytogen Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cytogen Inc to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.28 means that Cytogen Inc assets are financed with 27.8% credit (debt) and the remaining percentage (100% - 27.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cytogen Inc:

  • The MRQ is 0.278. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.356. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.278TTM0.356-0.078
TTM0.356YOY0.827-0.471
TTM0.3565Y0.472-0.116
5Y0.47210Y0.396+0.075
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2780.436-0.158
TTM0.3560.439-0.083
YOY0.8270.359+0.468
5Y0.4720.427+0.045
10Y0.3960.443-0.047
4.5.4.2. Debt to Equity Ratio

Measures if Cytogen Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 38.6% means that company has ₩0.39 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cytogen Inc:

  • The MRQ is 0.386. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.657. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.386TTM0.657-0.271
TTM0.657YOY6.167-5.510
TTM0.6575Y1.909-1.252
5Y1.90910Y1.516+0.393
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3860.640-0.254
TTM0.6570.673-0.016
YOY6.1670.502+5.665
5Y1.9090.666+1.243
10Y1.5160.712+0.804
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Cytogen Inc generates.

  • Above 15 is considered overpriced but always compare Cytogen Inc to the Diagnostics & Research industry mean.
  • A PE ratio of -16.11 means the investor is paying ₩-16.11 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cytogen Inc:

  • The EOD is -9.927. Based on the earnings, the company is expensive. -2
  • The MRQ is -16.109. Based on the earnings, the company is expensive. -2
  • The TTM is -21.829. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.927MRQ-16.109+6.182
MRQ-16.109TTM-21.829+5.721
TTM-21.829YOY-36.933+15.104
TTM-21.8295Y-218.398+196.569
5Y-218.39810Y-176.546-41.852
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-9.927-0.343-9.584
MRQ-16.109-0.463-15.646
TTM-21.829-0.881-20.948
YOY-36.933-0.020-36.913
5Y-218.3982.176-220.574
10Y-176.5464.721-181.267
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cytogen Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-30.824+30.824
TTM-30.824YOY-26.486-4.338
TTM-30.8245Y-11.462-19.362
5Y-11.46210Y-8.817-2.645
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.088+1.088
TTM-30.824-1.203-29.621
YOY-26.486-2.356-24.130
5Y-11.462-2.406-9.056
10Y-8.817-2.204-6.613
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cytogen Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.49 means the investor is paying ₩3.49 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Cytogen Inc:

  • The EOD is 2.150. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.489. Based on the equity, the company is fair priced.
  • The TTM is 12.714. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.150MRQ3.489-1.339
MRQ3.489TTM12.714-9.225
TTM12.714YOY71.919-59.205
TTM12.7145Y45.695-32.982
5Y45.69510Y36.624+9.072
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.1502.361-0.211
MRQ3.4892.347+1.142
TTM12.7142.314+10.400
YOY71.9192.384+69.535
5Y45.6953.646+42.049
10Y36.6244.369+32.255
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Operating Income  -2,225,670-688,388-2,914,058-151,675-3,065,733-281,924-3,347,6573,398,60950,952



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets75,605,834
Total Liabilities21,039,444
Total Stockholder Equity54,566,390
 As reported
Total Liabilities 21,039,444
Total Stockholder Equity+ 54,566,390
Total Assets = 75,605,834

Assets

Total Assets75,605,834
Total Current Assets55,741,785
Long-term Assets19,864,050
Total Current Assets
Total Current Assets  (as reported)55,741,785
Total Current Assets  (calculated)0
+/- 55,741,785
Long-term Assets
Long-term Assets  (as reported)19,864,050
Long-term Assets  (calculated)0
+/- 19,864,050

Liabilities & Shareholders' Equity

Total Current Liabilities3,225,922
Long-term Liabilities17,813,522
Total Stockholder Equity54,566,390
Total Current Liabilities
Total Current Liabilities  (as reported)3,225,922
Total Current Liabilities  (calculated)0
+/- 3,225,922
Long-term Liabilities
Long-term Liabilities  (as reported)17,813,522
Long-term Liabilities  (calculated)0
+/- 17,813,522
Total Stockholder Equity
Total Stockholder Equity (as reported)54,566,390
Total Stockholder Equity (calculated)0
+/- 54,566,390
Other
Common Stock Shares Outstanding 22,343
Net Invested Capital 54,566,390
Net Working Capital 52,515,863



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-06-302018-03-312017-03-31
> Total Assets 
0
5,983,907
5,286,022
22,752,889
23,092,029
22,036,056
21,326,579
19,716,116
19,609,341
17,301,131
25,731,537
28,310,535
27,492,104
61,349,313
59,722,431
55,527,740
53,863,716
46,044,588
45,249,322
41,220,348
39,387,478
33,332,286
25,390,316
74,450,070
77,617,443
75,605,834
75,605,83477,617,44374,450,07025,390,31633,332,28639,387,47841,220,34845,249,32246,044,58853,863,71655,527,74059,722,43161,349,31327,492,10428,310,53525,731,53717,301,13119,609,34119,716,11621,326,57922,036,05623,092,02922,752,8895,286,0225,983,9070
   > Total Current Assets 
0
4,524,408
2,783,836
20,198,632
19,443,357
18,503,382
17,906,293
14,281,195
14,282,766
11,984,993
19,625,510
22,400,159
21,379,633
51,020,666
49,471,647
43,588,920
42,188,548
34,237,589
33,708,186
19,388,887
15,448,187
9,929,318
2,391,251
56,003,180
58,318,277
55,741,785
55,741,78558,318,27756,003,1802,391,2519,929,31815,448,18719,388,88733,708,18634,237,58942,188,54843,588,92049,471,64751,020,66621,379,63322,400,15919,625,51011,984,99314,282,76614,281,19517,906,29318,503,38219,443,35720,198,6322,783,8364,524,4080
       Cash And Cash Equivalents 
0
3,888,793
2,467,482
2,092,642
985,676
6,684,925
1,204,385
10,065,183
326,913
642,543
10,103,234
11,075,534
6,359,537
12,530,471
11,882,058
30,287,911
1,100
2,251
2,827
596
893
1,567
614,397
54,837,579
42,813,749
0
042,813,74954,837,579614,3971,5678935962,8272,2511,10030,287,91111,882,05812,530,4716,359,53711,075,53410,103,234642,543326,91310,065,1831,204,3856,684,925985,6762,092,6422,467,4823,888,7930
       Short-term Investments 
0
110,000
0
0
0
10,751,955
15,130,317
2,756,665
0
0
8,117,061
4,818,800
9,000,000
26,960,189
20,077,932
5,088,895
7,077,678
2,045,343
2,064,750
223,167
2,163,918
2,193,903
357,924
49,463
13,022,564
0
013,022,56449,463357,9242,193,9032,163,918223,1672,064,7502,045,3437,077,6785,088,89520,077,93226,960,1899,000,0004,818,8008,117,061002,756,66515,130,31710,751,955000110,0000
       Net Receivables 
0
97,659
179,850
457,522
721,906
838,103
1,205,090
844,231
613,229
602,244
588,601
936,693
408,227
160,927
59,965
21,465
183,429
514,397
287,414
632,031
717,220
689,043
567,906
473,960
449,401
0
0449,401473,960567,906689,043717,220632,031287,414514,397183,42921,46559,965160,927408,227936,693588,601602,244613,229844,2311,205,090838,103721,906457,522179,85097,6590
       Other Current Assets 
0
110,780
124,492
1,198
1,397
228,400
176,019
455,600
136,461
332,875
218,255
5,083,819
5,096,857
11,267,205
17,362,535
7,824,186
7,872,882
2,253,022
2,351,213
2,043,700
381,362
342,552
0
-1
1
0
01-10342,552381,3622,043,7002,351,2132,253,0227,872,8827,824,18617,362,53511,267,2055,096,8575,083,819218,255332,875136,461455,600176,019228,4001,3971,198124,492110,7800
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,831,461
23,939,291
23,402,968
22,999,064
18,446,890
19,299,166
19,864,050
19,864,05019,299,16618,446,89022,999,06423,402,96823,939,29121,831,4610000000000000000000
       Property Plant Equipment 
0
844,104
1,968,992
1,630,739
2,813,478
2,681,956
2,550,461
2,373,261
2,188,371
2,114,841
1,906,557
1,732,841
1,940,328
2,126,297
2,055,453
2,808,423
2,554,367
2,670,668
2,413,208
3,104,211
4,996,710
4,711,993
4,512,806
4,980,294
5,376,998
0
05,376,9984,980,2944,512,8064,711,9934,996,7103,104,2112,413,2082,670,6682,554,3672,808,4232,055,4532,126,2971,940,3281,732,8411,906,5572,114,8412,188,3712,373,2612,550,4612,681,9562,813,4781,630,7391,968,992844,1040
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,711,630
176,693
5,916,695
6,060,917
2,722,550
2,843,750
0
02,843,7502,722,5506,060,9175,916,695176,6935,711,6300000000000000000000
       Long Term Investments 
0
0
0
0
0
0
297,116
1,999,992
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,999,992297,116000000
       Intangible Assets 
0
145,857
147,999
560,085
549,867
559,588
572,709
734,456
807,173
866,394
847,442
823,746
814,260
815,068
803,166
1,495,539
1,489,190
1,500,847
1,496,319
5,309,547
11,059,574
5,344,749
5,003,700
4,829,940
4,934,993
0
04,934,9934,829,9405,003,7005,344,74911,059,5745,309,5471,496,3191,500,8471,489,1901,495,539803,166815,068814,260823,746847,442866,394807,173734,456572,709559,588549,867560,085147,999145,8570
       Other Assets 
0
469,538
385,195
363,433
285,327
291,129
0
327,212
0
0
352,038
353,800
357,893
25,198
25,799
313,751
310,504
314,377
310,502
375,099
375,340
84,326
0
0
0
0
000084,326375,340375,099310,502314,377310,504313,75125,79925,198357,893353,800352,03800327,2120291,129285,327363,433385,195469,5380
> Total Liabilities 
0
1,964,182
1,851,334
711,505
1,909,207
1,747,504
1,741,156
1,796,078
2,913,029
1,925,314
11,842,184
9,973,615
10,200,280
34,279,357
35,412,572
32,518,750
33,311,100
33,439,366
34,002,008
35,564,131
36,355,716
25,697,073
15,175,371
21,094,677
20,532,638
21,039,444
21,039,44420,532,63821,094,67715,175,37125,697,07336,355,71635,564,13134,002,00833,439,36633,311,10032,518,75035,412,57234,279,35710,200,2809,973,61511,842,1841,925,3142,913,0291,796,0781,741,1561,747,5041,909,207711,5051,851,3341,964,1820
   > Total Current Liabilities 
0
1,474,213
1,353,617
488,167
1,032,461
955,232
987,226
1,074,989
2,222,575
1,303,316
1,267,281
1,170,154
1,328,933
1,183,453
1,105,398
6,791,151
6,783,368
32,481,366
33,117,331
33,929,851
34,655,050
23,980,040
13,255,859
10,747,185
3,183,094
3,225,922
3,225,9223,183,09410,747,18513,255,85923,980,04034,655,05033,929,85133,117,33132,481,3666,783,3686,791,1511,105,3981,183,4531,328,9331,170,1541,267,2811,303,3162,222,5751,074,989987,226955,2321,032,461488,1671,353,6171,474,2130
       Short-term Debt 
0
0
0
0
0
0
0
0
1,267,600
0
0
0
0
0
0
0
0
0
0
0
0
133,826
0
0
0
0
0000133,8260000000000001,267,60000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,757,659
26,697,705
19,055,498
9,837,190
7,979,947
754,126
0
0754,1267,979,9479,837,19019,055,49826,697,70525,757,6590000000000000000000
       Accounts payable 
0
82,240
4,764
69,232
118,975
184,098
200,646
141,452
76,542
56,977
164,626
67,089
56,804
0
0
0
0
56,804
56,804
189,201
238,944
218,844
0
206,641
243,783
0
0243,783206,6410218,844238,944189,20156,80456,804000056,80467,089164,62656,97776,542141,452200,646184,098118,97569,2324,76482,2400
       Other Current Liabilities 
0
1,037,843
970,536
236,775
286,387
400,471
415,918
333,272
878,433
336,842
703,699
444,256
669,279
0
0
0
0
7,118,246
7,130,454
1
6,609,753
2
0
0
0
0
000026,609,75317,130,4547,118,2460000669,279444,256703,699336,842878,433333,272415,918400,471286,387236,775970,5361,037,8430
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,634,280
1,700,666
1,717,033
1,919,512
10,347,492
17,349,543
17,813,522
17,813,52217,349,54310,347,4921,919,5121,717,0331,700,6661,634,2800000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
384,355
267,364
179,933
5,512,511
5,512,511
24,639,217
25,767,601
20,901,075
21,625,042
250,564
145,991
191,304
140,222
123,770
0
0
0
0
0000123,770140,222191,304145,991250,56421,625,04220,901,07525,767,60124,639,2175,512,5115,512,511179,933267,364384,35500000000
       Other Liabilities 
0
489,969
497,717
223,338
224,823
204,811
244,169
262,182
690,455
354,635
394,970
3,290,950
3,358,836
0
0
0
0
707,436
738,686
0
1,560,444
0
0
0
0
0
000001,560,4440738,686707,43600003,358,8363,290,950394,970354,635690,455262,182244,169204,811224,823223,338497,717489,9690
       Deferred Long Term Liability 
0
107,934
83,671
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000083,671107,9340
> Total Stockholder Equity
475,511
4,019,725
3,434,688
22,041,384
21,182,823
20,288,552
19,585,424
17,920,039
16,696,311
15,375,816
13,889,353
18,336,920
17,291,824
27,069,957
24,309,859
23,008,989
20,552,615
12,605,222
11,247,314
5,656,217
3,031,762
7,635,213
10,214,944
53,355,393
57,084,805
54,566,390
54,566,39057,084,80553,355,39310,214,9447,635,2133,031,7625,656,21711,247,31412,605,22220,552,61523,008,98924,309,85927,069,95717,291,82418,336,92013,889,35315,375,81616,696,31117,920,03919,585,42420,288,55221,182,82322,041,3843,434,6884,019,725475,511
   Common Stock
0
2,198,932
2,198,932
2,816,932
2,816,932
2,816,932
2,816,932
2,816,932
2,816,932
2,816,932
2,816,932
2,816,932
2,824,432
2,831,932
2,831,932
2,947,030
2,955,693
2,975,693
8,879,492
8,934,294
8,937,281
9,141,915
0
0
0
0
00009,141,9158,937,2818,934,2948,879,4922,975,6932,955,6932,947,0302,831,9322,831,9322,824,4322,816,9322,816,9322,816,9322,816,9322,816,9322,816,9322,816,9322,816,9322,816,9322,198,9322,198,9320
   Retained Earnings Total Equity00000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
32,984,574
33,003,818
33,043,935
33,079,937
38,314,864
38,702,838
50,173,706
50,173,706
54,635,191
54,982,086
54,734,616
49,243,727
50,758,748
50,850,861
56,363,249
0
0
0
0
000056,363,24950,850,86150,758,74849,243,72754,734,61654,982,08654,635,19150,173,70650,173,70638,702,83838,314,86433,079,93733,043,93533,003,81832,984,5740000000
   Treasury Stock0000000000-3,234,000-3,234,000-3,234,0000000000000000
   Other Stockholders Equity 
0
-36,615
462,278
-78,589
-78,880
-70,611
-62,061
-109,703
-41,122
-2,173
33,121
466,415
612,574
-127,982
-94,661
-78,429
-78,429
-69,964
803,185
-2,903,742
2,710,471
-1,935,365
0
0
0
0
0000-1,935,3652,710,471-2,903,742803,185-69,964-78,429-78,429-94,661-127,982612,574466,41533,121-2,173-41,122-109,703-62,061-70,611-78,880-78,589462,278-36,6150



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,184,361
Cost of Revenue-2,338,140
Gross Profit846,221846,221
 
Operating Income (+$)
Gross Profit846,221
Operating Expense-14,975,966
Operating Income-11,791,606-14,129,746
 
Operating Expense (+$)
Research Development3,117,124
Selling General Administrative2,913,466
Selling And Marketing Expenses-
Operating Expense14,975,9666,030,590
 
Net Interest Income (+$)
Interest Income216,605
Interest Expense-3,036,506
Other Finance Cost-968,315
Net Interest Income-1,851,587
 
Pretax Income (+$)
Operating Income-11,791,606
Net Interest Income-1,851,587
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-16,179,271-11,791,606
EBIT - interestExpense = -3,036,506
-15,769,501
-12,732,994
Interest Expense3,036,506
Earnings Before Interest and Taxes (EBIT)--13,142,765
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-16,179,271
Tax Provision--409,770
Net Income From Continuing Ops-15,769,501-15,769,501
Net Income-15,769,501
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-1,851,587
 

Technical Analysis of Cytogen Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cytogen Inc. The general trend of Cytogen Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cytogen Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cytogen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 6,370 < 6,430 < 6,540.

The bearish price targets are: .

Tweet this
Cytogen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cytogen Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cytogen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cytogen Inc. The current macd is -300.25245093.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cytogen Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cytogen Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cytogen Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Cytogen Inc Daily Moving Average Convergence/Divergence (MACD) ChartCytogen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cytogen Inc. The current adx is 18.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cytogen Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Cytogen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cytogen Inc. The current sar is 7,883.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cytogen Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cytogen Inc. The current rsi is 25.32. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Cytogen Inc Daily Relative Strength Index (RSI) ChartCytogen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cytogen Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cytogen Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cytogen Inc Daily Stochastic Oscillator ChartCytogen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cytogen Inc. The current cci is -327.46414656.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Cytogen Inc Daily Commodity Channel Index (CCI) ChartCytogen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cytogen Inc. The current cmo is -63.10159552.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cytogen Inc Daily Chande Momentum Oscillator (CMO) ChartCytogen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cytogen Inc. The current willr is -88.78648233.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Cytogen Inc Daily Williams %R ChartCytogen Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cytogen Inc.

Cytogen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cytogen Inc. The current atr is 543.09.

Cytogen Inc Daily Average True Range (ATR) ChartCytogen Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cytogen Inc. The current obv is -879,647.

Cytogen Inc Daily On-Balance Volume (OBV) ChartCytogen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cytogen Inc. The current mfi is 23.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cytogen Inc Daily Money Flow Index (MFI) ChartCytogen Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cytogen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Cytogen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cytogen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.318
Ma 20Greater thanMa 506,960.500
Ma 50Greater thanMa 1007,200.200
Ma 100Greater thanMa 2007,659.700
OpenGreater thanClose6,290.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cytogen Inc with someone you think should read this too:
  • Are you bullish or bearish on Cytogen Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cytogen Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cytogen Inc

I send you an email if I find something interesting about Cytogen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cytogen Inc.

Receive notifications about Cytogen Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.